KS-101

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameKS-101
Drug Alias Nameisatin derivatives (Penn State College of Medicine)KS-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRenal Insufficiency, ChronicAlzheimer DiseaseMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPenn State College of Medicine
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, ChronicAlzheimer DiseaseMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A